Prostate cancer detection with 3 T MRI: Comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 3, 2010, Pages 625-631

  Kitajima, Kazuhiro ^a,b   Kaji, Yasushi ^a   Fukabori, Yoshitatsu ^a   Yoshida, Ken Ichiro ^a   Suganuma, Narufumi ^c   Sugimura, Kazuro ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

3 T MRI; Diffusion weighted imaging (DWI); Dynamic contrast enhanced imaging; Prostate cancer

Indexed keywords

GADOLINIUM PENTETATE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALGORITHMS; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 77649230687     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22075     Document Type: Article

References (31)

1. American Cancer Society.Cancer facts and figures 2008 Atlanta (GA): American Cancer Society; 2008.
2. Akduman B, Barqawi AB, Crawford ED. Minimally invasive surgery in prostate cancer: current and future perspectives. Cancer J 2005;11:355-361.
3. Zelefsky MJ. Three-dimensional conformal brachytherapy for prostate cancer. Curr Urol Rep 2004;5:173-178.
4. Gelet A, Chapelon JY, Bouvier R, et al. Transrectal high intensity focues ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001;40:124-129.
5. Gardner TA, Koch MO. Prostate cancer therapy with highintensity focused ultrasound. Clin Genitourin Cancer 2005;4: 187-192.
6. Amsellem-Ouazana D, Younes P, Coquy S, et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool. A preliminary study. Eur Urol 2005;47:582-586.
7. Al-Ghazo MA, Ghalayini IF, Matalka II. Ultrasound-guided transrectal extended prostate biopsy: a prospective study. Asian J Androl 2005;7:165-169.
8. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrastenhanced MRI for prostate cancer diagnosis: correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24: 108-113.
9. Tanimoto A, Nakashima J, Hidaka K, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007;25:146-152.
10. Girouin N, Mege-Lechevallier F, Senes AT, et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 2007;17:1498-1509.
11. Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008;248:531-539.
12. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008;27:132-139.
13. Yoshizako T, Wada T, Hayashi K, et al. Usefulness of diffusionweighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008;10:1207-1213.
14. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusionweighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009;30:327-334.
15. Sosna J, Pedrosa I, Dewolf WC, et al. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 2004;11:857-862.
16. Kaji Y, Kuroda K, Maeda T, et al. Anatomical and metabolic assessment of prostate using a 3 Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study. J Magn Reson Imaging 2007;25:517-526.
17. Futterer JJ, Scheenen TW, Huisman HJ, et al. Initial experience of 3 Tesla endorectal coil magnetic resonance imaging and 1Hspectroscopic imaging of the prostate. Invest Radiol 2004;39: 671-680.
18. Heijmink SWTPJ, Futtere JJ, Hambrock T, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3T - comparison of image quality, and staging performance. Radiology 2007; 244:184-195.
19. Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 2007;42: 842-847.
20. Miao H, Fukatsu H, Ishigaki T. Prostate cancer detection with 3-T MRI: Comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 2007;61:297-302.
21. Yu JS, Chung JJ, Hong SW, Chung BH, Kim JH, Kim KW. Prostate cancer: added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil. Yonsei Med J 2008;49:765-774.
22. Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrastenhanced imaging. J Comput Assist Tomogr 2006;30:7-11.
23. Hambrock T, Futterer JJ, Huisman HJ, et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 2008;43: 686-694.
24. Cleves M. receiver operating characteristic (ROC) analysis. Stata Tech Bull 1999;52:19-33.
25. Delong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics 1988;44:837-845.
26. Yu KK, Hricak H, Alagappan R, et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phasedarray coil MR imaging: multivariate feature analysis. Radiology 1997;202:697-702.
27. Cruz M, Tsuda K, Narumi Y, et al. Characterization of low intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 2002;12:357-365.
28. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239:784-792.
29. Preziosi P, Orlacchio A, Di Giambattista G, et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 2003;13: 925-930.
30. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging: initial experience. Radiology 2004;233:709-715.
31. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005;21:258-262.